← March 3, 2026 briefing
Weight-Loss Drugs May Prevent Fatal Heart Attack Complications
Health

Weight-Loss Drugs May Prevent Fatal Heart Attack Complications

A UK study has found that GLP-1 drugs such as Ozempic and Wegovy can reduce the tissue damage known as "no-reflow" that occurs when blood flow fails to return to the heart after a blockage is cleared. The complication affects up to half of the 100,000 people who suffer a heart attack in the UK each year, making it a significant killer. The research is based on animal model trials and points to a major new therapeutic use beyond weight loss and diabetes management.

Sources
Weight-loss drugs could prevent fatal complications from heart attacks, UK study finds

Weight-loss drugs could prevent fatal complications from heart attacks, UK study finds

The Guardian · Mar 3

More from today's briefing

US-Israel War on Iran Enters Deadly Third Day
World

US-Israel War on Iran Enters Deadly Third Day

Economy

Strait of Hormuz Closure Sends Energy Markets Into Chaos

France Expands Nuclear Arsenal Amid European Security Fears
World

France Expands Nuclear Arsenal Amid European Security Fears

OpenAI Revises Pentagon Deal Over Surveillance Concerns
Tech

OpenAI Revises Pentagon Deal Over Surveillance Concerns